Breaking News Instant updates and real-time market news.

MARA

Marathon Digital

$28.60 /

+0.52 (+1.85%)

05:14
01/18/22
01/18
05:14
01/18/22
05:14

Marathon Digital initiated with a Buy at BTIG

BTIG analyst Gregory Lewis initiated coverage of Marathon Digital with a Buy rating and $50 price target. Mara was an early mover in the bitcoin mining sector having started mining in 2017, Lewis tells investors in a research note. The company currently has hash capacity of 33,000 rigs, which points to 1.9% of current global hash capacity, making it one of the largest publicly traded bitcoin miners by capacity, adds the analyst. He believes the company is well positioned for the ongoing bitcoin mining up-cycle.

OTHER BREAKING NEWS FROM THE FLY

General news
June investor movement index 5.10  20:32
07/05/22
07/05
20:32
07/05/22
20:32
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
6-month bill auction » 20:32
07/05/22
07/05
20:32
07/05/22
20:32
$ECON

Economic Data

/

+

Total Amount: $42B,…

Total Amount: $42B, Bid/Cover: 2.57, Rate: 2.500%.

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
3-month bill auction » 20:32
07/05/22
07/05
20:32
07/05/22
20:32
$ECON

Economic Data

/

+

Total Amount: $45B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Biogen says FDA accepts BLA for lecanemab under accelerated approval pathway » 20:02
07/05/22
07/05
20:02
07/05/22
20:02
BIIB

Biogen

$212.55 /

+1.95 (+0.93%)

, ESALY

Eisai

$42.97 /

+0.39 (+0.92%)

Eisai (ESALY) and Biogen…

Eisai (ESALY) and Biogen (BIIB) announced that the U.S. Food and Drug Administration has accepted the Biologics License Application, or BLA, under the accelerated approval pathway for lecanemab, an investigational anti-amyloid beta protofibril antibody for the treatment of mild cognitive impairment due to Alzheimer's disease and mild AD with confirmed presence of amyloid pathology in the brain. Eisai's application, which was completed in early May 2022, has been granted Priority Review, with a Prescription Drug User Fee Act, or PDUFA, action date of January 6, 2023. Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority. The Clarity AD Phase 3 clinical study for lecanemab in early AD is ongoing and Eisai completed enrollment in March 2021 with 1,795 patients. The readout of the primary endpoint data of Clarity AD will occur in the Fall of 2022. The FDA has agreed that the results of Clarity AD, when completed, can serve as the confirmatory study to verify the clinical benefit of lecanemab. Eisai utilized the FDA's Accelerated Approval Pathway in an effort to streamline the submission process for the potential traditional approval of lecanemab in order to expedite patients' access to lecanemab. Dependent upon the results of the Clarity AD clinical trial, Eisai will submit for traditional approval of lecanemab to the FDA during Eisai's fiscal year 2022, which ends on March 31, 2023. Haruo Naito, Chief Executive Officer at Eisai, said, "The acceptance of lecanemab's BLA with priority review is an important milestone in serving people living with Alzheimer's disease who have been waiting for new treatment options to address an underlying pathology of Alzheimer's disease. We will continue to actively cooperate with the FDA's review in an effort to bring this new treatment option to people living with Alzheimer's disease and their families as soon as possible."

ShowHide Related Items >><<
ESALY Eisai
$42.97 /

+0.39 (+0.92%)

BIIB Biogen
$212.55 /

+1.95 (+0.93%)

BIIB Biogen
$212.55 /

+1.95 (+0.93%)

06/21/22 Jefferies
Jefferies downgrades Acadia to Underperform after 'wrong call' on AdCom
06/02/22 Univest Securities
Univest keeps Sell on Cassava after medical journal retracts article
06/01/22 Piper Sandler
Sage Therapeutics data better than Street expectations, says Piper Sandler
05/23/22 Piper Sandler
Piper Sandler remains bullish on Catalyst after sale of complement portfolio
ESALY Eisai
$42.97 /

+0.39 (+0.92%)

04/08/22 William Blair
CMS decision to substantially limit Biogen opportunity, says William Blair
03/28/22 BofA
Biogen price target lowered to $225 from $230 at BofA
01/13/22 Citi
Eisai downgraded to Neutral from Buy at Citi
10/08/21 Jefferies
Biogen price target lowered to $400 from $500 at Jefferies
BIIB Biogen
$212.55 /

+1.95 (+0.93%)

BIIB Biogen
$212.55 /

+1.95 (+0.93%)

ESALY Eisai
$42.97 /

+0.39 (+0.92%)

BIIB Biogen
$212.55 /

+1.95 (+0.93%)

BIIB Biogen
$212.55 /

+1.95 (+0.93%)

Hot Stocks
Nexa Resources announces Aripuana ramp up » 18:53
07/05/22
07/05
18:53
07/05/22
18:53
NEXA

Nexa Resources

$5.80 /

-0.29 (-4.76%)

Nexa Resources announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEXA Nexa Resources
$5.80 /

-0.29 (-4.76%)

NEXA Nexa Resources
$5.80 /

-0.29 (-4.76%)

03/23/22 Morgan Stanley
Nexa Resources price target raised to $9.80 from $8.00 at Morgan Stanley
10/29/21 Morgan Stanley
Nexa Resources downgraded to Equal Weight from Overweight at Morgan Stanley
09/28/21 Morgan Stanley
Nexa Resources upgraded to Overweight from Equal Weight at Morgan Stanley
08/19/21 BMO Capital
Nexa Resources upgraded to Market Perform from Underperform at BMO Capital
Periodicals
Nasdaq, NYSE victorious in market data court dispute with SEC, WSJ reports » 18:33
07/05/22
07/05
18:33
07/05/22
18:33
NDAQ

Nasdaq

$157.45 /

+1.92 (+1.23%)

, ICE

IntercontinentalExchange

$96.00 /

+0.78 (+0.82%)

A three-judge panel of…

A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit partly dismissed an SEC plan to loosen the control that stock exchanges have over public market-data feeds, a win for Nasdaq (NDAQ) and ICE's (ICE) New York Stock Exchange, the Wall Street Journal's Alexander Osipovich reports. The panel determined that the SEC had exceeded its authority under federal law when it issued an order two years ago revamping the governance of the data feeds, the author notes. Reference Link

ShowHide Related Items >><<
NDAQ Nasdaq
$157.45 /

+1.92 (+1.23%)

ICE IntercontinentalExchange
$96.00 /

+0.78 (+0.82%)

NDAQ Nasdaq
$157.45 /

+1.92 (+1.23%)

06/27/22 Jefferies
Nasdaq price target lowered to $174 from $182 at Jefferies
05/19/22 Deutsche Bank
Nasdaq price target lowered to $184 from $207 at Deutsche Bank
04/21/22 Deutsche Bank
Nasdaq price target lowered to $207 from $210 at Deutsche Bank
04/13/22 Citi
Nasdaq price target lowered to $184 from $188 at Citi
ICE IntercontinentalExchange
$96.00 /

+0.78 (+0.82%)

06/22/22 Raymond James
IntercontinentalExchange price target lowered to $126 from $142 at Raymond James
06/01/22 Argus
IntercontinentalExchange price target lowered to $138 from $148 at Argus
05/20/22 Jefferies
IntercontinentalExchange price target lowered to $134 from $161 at Jefferies
05/19/22 Deutsche Bank
IntercontinentalExchange price target lowered to $117 from $143 at Deutsche Bank
NDAQ Nasdaq
$157.45 /

+1.92 (+1.23%)

ICE IntercontinentalExchange
$96.00 /

+0.78 (+0.82%)

NDAQ Nasdaq
$157.45 /

+1.92 (+1.23%)

ICE IntercontinentalExchange
$96.00 /

+0.78 (+0.82%)

NDAQ Nasdaq
$157.45 /

+1.92 (+1.23%)

ICE IntercontinentalExchange
$96.00 /

+0.78 (+0.82%)

Hot Stocks
SilverBow Resources raises FY22 production view to 272-282 from 235-255 MMCFE/D » 18:22
07/05/22
07/05
18:22
07/05/22
18:22
SBOW

SilverBow Resources

$24.44 /

-3.66 (-13.02%)

SilverBow also estimates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

04/21/22 Truist
SilverBow Resources price target raised to $62 from $50 at Truist
04/18/22 Truist
SilverBow Resources price target raised to $50 from $39 at Truist
01/14/22 Truist
SilverBow Resources price target lowered to $39 from $43 at Truist
10/12/21 Truist
SilverBow Resources price target raised to $43 from $40 at Truist
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

On The Fly
Fly Intel: After-Hours Movers » 18:18
07/05/22
07/05
18:18
07/05/22
18:18
ESTE

Earthstone Energy

$12.46 /

-1.125 (-8.28%)

, SBOW

SilverBow Resources

$24.44 /

-3.66 (-13.02%)

, LSI

Life Storage

$114.15 /

-1.32 (-1.14%)

, KRNT

Kornit Digital

$31.55 /

+0.41 (+1.32%)

Check out this evening's…

ShowHide Related Items >><<
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

LSI Life Storage
$114.15 /

-1.32 (-1.14%)

KRNT Kornit Digital
$31.55 /

+0.41 (+1.32%)

ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

06/29/22 Truist
Earthstone Energy price target raised to $35 from $30 at Truist
04/21/22 Truist
Earthstone Energy price target raised to $30 from $25 at Truist
04/13/22 Stephens
Earthstone Energy initiated with an Equal Weight at Stephens
02/11/22 Alliance Global Partners
Earthstone Energy price target raised to $33 from $28 at Alliance Global Partners
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

04/21/22 Truist
SilverBow Resources price target raised to $62 from $50 at Truist
04/18/22 Truist
SilverBow Resources price target raised to $50 from $39 at Truist
01/14/22 Truist
SilverBow Resources price target lowered to $39 from $43 at Truist
10/12/21 Truist
SilverBow Resources price target raised to $43 from $40 at Truist
LSI Life Storage
$114.15 /

-1.32 (-1.14%)

06/30/22 Jefferies
Life Storage price target lowered to $127 from $166 at Jefferies
06/21/22 BofA
Life Storage downgraded to Neutral from Buy at BofA
06/01/22 Truist
Life Storage price target lowered to $132 from $138 at Truist
05/23/22 Raymond James
Life Storage price target lowered to $125 from $145 at Raymond James
KRNT Kornit Digital
$31.55 /

+0.41 (+1.32%)

05/12/22 Citi
Kornit Digital selloff an attractive buying opportunity, says Citi
04/21/22 Needham
Kornit Digital price target lowered to $155 from $202 at Needham
02/16/22 Citi
Kornit Digital earnings selloff a buying opportunity, says Citi
02/09/22 Craig-Hallum
Kornit Digital price target lowered to $135 from $180 at Craig-Hallum
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

LSI Life Storage
$114.15 /

-1.32 (-1.14%)

KRNT Kornit Digital
$31.55 /

+0.41 (+1.32%)

ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

  • 19
    Nov
  • 14
    Sep
SBOW SilverBow Resources
$24.44 /

-3.66 (-13.02%)

LSI Life Storage
$114.15 /

-1.32 (-1.14%)

KRNT Kornit Digital
$31.55 /

+0.41 (+1.32%)

Hot Stocks
Ubisoft announces two upcoming Ubisoft Forward events » 18:16
07/05/22
07/05
18:16
07/05/22
18:16
UBSFY

Ubisoft

$8.81 /

+ (+0.00%)

Ubisoft said that Ubisoft…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBSFY Ubisoft
$8.81 /

+ (+0.00%)

UBSFY Ubisoft
$8.81 /

+ (+0.00%)

08:27 Today Societe Generale
Ubisoft resumed with a Buy at Societe Generale
06/23/22 Deutsche Bank
Ubisoft initiated with a Buy at Deutsche Bank
06/09/22 Goldman Sachs
Ubisoft price target raised to EUR 45 from EUR 40 at Goldman Sachs
06/02/22 Societe Generale
Ubisoft price target raised to EUR 59 from EUR 55.30 at Societe Generale
UBSFY Ubisoft
$8.81 /

+ (+0.00%)

UBSFY Ubisoft
$8.81 /

+ (+0.00%)

UBSFY Ubisoft
$8.81 /

+ (+0.00%)

Hot Stocks
Lockheed Martin awarded $185.92M Navy contract modification » 18:06
07/05/22
07/05
18:06
07/05/22
18:06
LMT

Lockheed Martin

$414.96 /

-18.35 (-4.23%)

Lockheed Martin was…

Lockheed Martin was awarded a $185.92M cost-plus-incentive-fee contract modification to previously awarded contract to exercise an option for engineering design and development. Work is expected to be completed by September 2023. FY22 research, development, test and evaluation funds in the amount of $17.83M and FY22 shipbuilding and conversion funds in the amount of $535,657 will be obligated at the time of award and will not expire at the end of the current fiscal year. The Naval Sea Systems Command is the contracting activity.

ShowHide Related Items >><<
LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

04/20/22 Argus
Lockheed Martin price target raised to $500 from $415 at Argus
04/20/22 Wells Fargo
Lockheed Martin price target raised to $496 from $486 at Wells Fargo
04/20/22 Susquehanna
Lockheed Martin price target raised to $539 from $515 at Susquehanna
04/08/22 Canaccord
Canaccord starts 'premier' small satellite maker Terran Orbital at Buy
LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

LMT Lockheed Martin
$414.96 /

-18.35 (-4.23%)

Periodicals
Walmart to add new fee for some suppliers due to fuel, transport costs, WSJ says » 17:44
07/05/22
07/05
17:44
07/05/22
17:44
WMT

Walmart

$124.12 /

+1.455 (+1.19%)

According to a memo…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$124.12 /

+1.455 (+1.19%)

WMT Walmart
$124.12 /

+1.455 (+1.19%)

06/27/22 Goldman Sachs
Walmart price target lowered to $138 from $160 at Goldman Sachs
06/23/22 Baird
Symbotic initiated with an Outperform at Baird
06/21/22 Cowen
Symbotic initiated with an Outperform at Cowen
06/17/22 Truist
Deal with Walmart an 'incremental positive' for Roku, says Truist
WMT Walmart
$124.12 /

+1.455 (+1.19%)

WMT Walmart
$124.12 /

+1.455 (+1.19%)

WMT Walmart
$124.12 /

+1.455 (+1.19%)

WMT Walmart
$124.12 /

+1.455 (+1.19%)

Periodicals
McKesson, Cardinal, AmerisourceBergen not liable for WV opioid crisis, WSJ says » 17:39
07/05/22
07/05
17:39
07/05/22
17:39
MCK

McKesson

$322.22 /

-7.13 (-2.16%)

, CAH

Cardinal Health

$52.27 /

-0.83 (-1.56%)

, ABC

AmerisourceBergen

$140.71 /

-2.425 (-1.69%)

Federal U.S. District…

Federal U.S. District judge David Faber has ruled that opioid distributors, McKesson (MCK), Cardinal (CAH), and AmerisourceBergen (ABC) are not liable for the opioid epidemic in West Virginia, The Wall Street Journal's Corinne Ramey and Sara Randazzo report. Reference Link

ShowHide Related Items >><<
MCK McKesson
$322.22 /

-7.13 (-2.16%)

CAH Cardinal Health
$52.27 /

-0.83 (-1.56%)

ABC AmerisourceBergen
$140.71 /

-2.425 (-1.69%)

MCK McKesson
$322.22 /

-7.13 (-2.16%)

06/07/22 Deutsche Bank
Deutsche Bank upgrades McKesson to Buy amid recession concerns
06/07/22 Deutsche Bank
McKesson upgraded to Buy from Hold at Deutsche Bank
05/11/22 Credit Suisse
McKesson price target raised to $377 from $333 at Credit Suisse
05/10/22 Deutsche Bank
McKesson price target raised to $343 from $270 at Deutsche Bank
CAH Cardinal Health
$52.27 /

-0.83 (-1.56%)

05/26/22 Barclays
Cardinal Health downgraded to Equal Weight from Overweight at Barclays
05/18/22 Evercore ISI
Evercore upgrades Cardinal Health to Outperform on undervalued Medical segment
05/18/22 Evercore ISI
Cardinal Health upgraded to Outperform from In Line at Evercore ISI
04/12/22 Morgan Stanley
McKesson price target raised to $370 from $292 at Morgan Stanley
ABC AmerisourceBergen
$140.71 /

-2.425 (-1.69%)

06/13/22 UBS
AmerisourceBergen price target raised to $174 from $144 at UBS
06/09/22 Cowen
AmerisourceBergen price target lowered to $170 from $171 at Cowen
06/07/22 Deutsche Bank
AmerisourceBergen upgraded to Buy on conservative outlook at Deutsche Bank
06/07/22 Deutsche Bank
AmerisourceBergen upgraded to Buy from Hold at Deutsche Bank
MCK McKesson
$322.22 /

-7.13 (-2.16%)

CAH Cardinal Health
$52.27 /

-0.83 (-1.56%)

ABC AmerisourceBergen
$140.71 /

-2.425 (-1.69%)

MCK McKesson
$322.22 /

-7.13 (-2.16%)

MCK McKesson
$322.22 /

-7.13 (-2.16%)

CAH Cardinal Health
$52.27 /

-0.83 (-1.56%)

ABC AmerisourceBergen
$140.71 /

-2.425 (-1.69%)

MCK McKesson
$322.22 /

-7.13 (-2.16%)

Hot Stocks
Nexa Resources says ramp-up activities at Aripuana start » 17:25
07/05/22
07/05
17:25
07/05/22
17:25
NEXA

Nexa Resources

$5.80 /

-0.29 (-4.76%)

"Nexa Resources is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NEXA Nexa Resources
$5.80 /

-0.29 (-4.76%)

NEXA Nexa Resources
$5.80 /

-0.29 (-4.76%)

03/23/22 Morgan Stanley
Nexa Resources price target raised to $9.80 from $8.00 at Morgan Stanley
10/29/21 Morgan Stanley
Nexa Resources downgraded to Equal Weight from Overweight at Morgan Stanley
09/28/21 Morgan Stanley
Nexa Resources upgraded to Overweight from Equal Weight at Morgan Stanley
08/19/21 BMO Capital
Nexa Resources upgraded to Market Perform from Underperform at BMO Capital
Hot Stocks
Xometry CEO sells 20K shares of common stock » 17:25
07/05/22
07/05
17:25
07/05/22
17:25
XMTR

Xometry

$33.99 /

+0.145 (+0.43%)

In a regulatory filing,…

In a regulatory filing, Xometry disclosed that its CEO Randolph Altschuler sold 20K shares of common stock on July 1st in a total transaction size of $659.2K.

ShowHide Related Items >><<
XMTR Xometry
$33.99 /

+0.145 (+0.43%)

XMTR Xometry
$33.99 /

+0.145 (+0.43%)

06/09/22 Goldman Sachs
Xometry price target lowered to $44 from $51 at Goldman Sachs
05/12/22 CL King
Xometry price target lowered to $55 from $65 at CL King
04/11/22 Loop Capital
Loop Capital starts Xometry at Buy, expects 'significant' growth to continue
04/11/22 Loop Capital
Xometry initiated with a Buy at Loop Capital
XMTR Xometry
$33.99 /

+0.145 (+0.43%)

XMTR Xometry
$33.99 /

+0.145 (+0.43%)

Hot Stocks
SCWorx enters $5M common stock purchase agreement with investor » 17:15
07/05/22
07/05
17:15
07/05/22
17:15
WORX

SCWorx

/

+

SCWorx "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WORX SCWorx
/

+

Conference/Events
Nuvalent management to meet virtually with Piper Sandler » 17:11
07/05/22
07/05
17:11
07/05/22
17:11
NUVL

Nuvalent

$14.91 /

+1.36 (+10.04%)

Virtual Meeting to be…

Virtual Meeting to be held on July 14 hosted by Piper Sandler.

ShowHide Related Items >><<
NUVL Nuvalent
$14.91 /

+1.36 (+10.04%)

NUVL Nuvalent
$14.91 /

+1.36 (+10.04%)

06/23/22 BMO Capital
Nuvalent initiated with an Outperform at BMO Capital
09/08/21 Piper Sandler
Nuvalent's Q2 results essentially in-line, says Piper Sandler
08/23/21 Cowen
Nuvalent initiated with an Outperform on tumor 'potency' at Cowen
08/23/21 JPMorgan
Nuvalent initiated with an Overweight, $34 target at JPMorgan
NUVL Nuvalent
$14.91 /

+1.36 (+10.04%)

  • 29
    Jul
NUVL Nuvalent
$14.91 /

+1.36 (+10.04%)

Conference/Events
Piper Sandler healthcare analysts to hold analyst/industry conference call » 17:10
07/05/22
07/05
17:10
07/05/22
17:10

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Vornado completes sale of Center Building in Long Island City, NY for $172.8M » 17:06
07/05/22
07/05
17:06
07/05/22
17:06
VNO

Vornado

$30.20 /

+0.75 (+2.55%)

Vornado Realty Trust…

Vornado Realty Trust announced that it has completed the previously announced sale of the Center Building, an eight-story 498,000 square foot office building located at 33-00 Northern Boulevard in Long Island City, New York, for $172.8M. The financial statement gain, which will be recognized in the second quarter, is estimated to be $15M. The tax gain is estimated to be $74M.

ShowHide Related Items >><<
VNO Vornado
$30.20 /

+0.75 (+2.55%)

VNO Vornado
$30.20 /

+0.75 (+2.55%)

06/30/22 Truist
Vornado price target lowered to $34 from $41 at Truist
06/15/22 Truist
Vornado price target lowered to $41 from $51 at Truist
05/31/22 BMO Capital
Boston Properties top pick among Office REITs, says BMO Capital
05/31/22 BMO Capital
Vornado downgraded to Market Perform from Outperform at BMO Capital
VNO Vornado
$30.20 /

+0.75 (+2.55%)

Syndicate
Earthstone Energy files to sell 19.4M shares of common stock for holders  17:05
07/05/22
07/05
17:05
07/05/22
17:05
ESTE

Earthstone Energy

$12.46 /

-1.125 (-8.28%)

 
ShowHide Related Items >><<
ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

06/29/22 Truist
Earthstone Energy price target raised to $35 from $30 at Truist
04/21/22 Truist
Earthstone Energy price target raised to $30 from $25 at Truist
04/13/22 Stephens
Earthstone Energy initiated with an Equal Weight at Stephens
02/11/22 Alliance Global Partners
Earthstone Energy price target raised to $33 from $28 at Alliance Global Partners
ESTE Earthstone Energy
$12.46 /

-1.125 (-8.28%)

Hot Stocks
Primoris awarded contract at over $170M » 17:01
07/05/22
07/05
17:01
07/05/22
17:01
PRIM

Primoris

$21.65 /

-0.255 (-1.16%)

Primoris Services…

Primoris Services "announced a heavy civil project valued at more than $170 million. The project, secured by the Company's Energy/Renewables Segment, was awarded by the Texas Department of Transportation. The project involves construction of a section of Highway 59 in Polk County, Texas. It is scheduled to commence in the third quarter of 2022 with completion expected in the fourth quarter of 2024."

ShowHide Related Items >><<
PRIM Primoris
$21.65 /

-0.255 (-1.16%)

PRIM Primoris
$21.65 /

-0.255 (-1.16%)

11/10/21 Goldman Sachs
Goldman downgrades Primoris to Sell on 'bottom quintile' growth
11/10/21 Goldman Sachs
Primoris downgraded to Sell from Neutral at Goldman Sachs
07/16/21
Fly Intel: Top five analyst initiations
07/16/21 UBS
Primoris initiated with a Buy at UBS
PRIM Primoris
$21.65 /

-0.255 (-1.16%)

Hot Stocks
Stride joins S&P SmallCap 600 » 17:00
07/05/22
07/05
17:00
07/05/22
17:00
LRN

Stride

$40.29 /

-1.08 (-2.61%)

Stride was added to the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LRN Stride
$40.29 /

-1.08 (-2.61%)

LRN Stride
$40.29 /

-1.08 (-2.61%)

04/21/22 Citi
Citi remains buyer of Stride with $65 price target
04/20/22 Barrington
Stride price target raised to $50 from $45 at Barrington
09/14/21
Fly Intel: Top five analyst initiations
09/14/21 Citi
Stride initiated with a Buy at Citi
LRN Stride
$40.29 /

-1.08 (-2.61%)

LRN Stride
$40.29 /

-1.08 (-2.61%)

LRN Stride
$40.29 /

-1.08 (-2.61%)

Hot Stocks
U.S. DOT reassigns 16 'peak-hour' runway timings to Spirit Airlines » 16:59
07/05/22
07/05
16:59
07/05/22
16:59
LUV

Southwest

$36.52 /

-0.205 (-0.56%)

, SAVE

Spirit Airlines

$24.14 /

-0.415 (-1.69%)

, UAL

United Airlines

$36.98 /

+0.53 (+1.45%)

, ALK

Alaska Air

$41.55 /

+0.4 (+0.97%)

, JBLU

JetBlue

$8.57 /

+0.035 (+0.41%)

The agency said in part:…

The agency said in part: "The U.S. Department of Transportation reassigned, with conditions, 16 peak-hour runway timings, previously operated by Southwest Airlines (LUV), at Newark-Liberty International Airport to Spirit Airlines. Today's action secures low-cost service options for Newark customers and improves competition in the Newark market, which was affected when Southwest Airlines discontinued service there.Today's decision provides certainty to carriers that have been operating at Newark using temporary, ad hoc timings made available while other carriers reduced service during the COVID-19 pandemic. Given the Department's concern over the recent airline cancellations, delays, challenges with customer service and other operational disruptions that have hurt travelers, the Department is requiring Spirit (SAVE), as a condition of accepting the timings, to report additional data on disruptions facing their airline customers and its ability to provide them with accommodations...The 16 timings reassigned were originally operated by Southwest Airlines in 2010 when it acquired them as part of a Department of Justice competition remedy to the United-Continental (UAL) merger. The Department received applications from Spirit and JetBlue Airways (JBLU) for all 16 timings, and from Alaska Airlines (ALK) for four of the timings. After reviewing the applications against the decisional criteria announced by the Department, the Department found that Spirit will best be able to provide competition with all 16 timings, consistent with the Department of Justice's original competition remedy, and is most likely to provide the lowest fares to the most consumers." Reference Link

ShowHide Related Items >><<
UAL United Airlines
$36.98 /

+0.53 (+1.45%)

SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

ALK Alaska Air
$41.55 /

+0.4 (+0.97%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/22/22 Citi
Citi says this is not 2020 or 2008 for airline stocks
05/11/22 William Blair
ViaSat deal with Southwest 'solidifies industry dominance,' says William Blair
SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

06/27/22 Evercore ISI
Spirit Airlines price target raised to $28 from $25 at Evercore ISI
06/23/22 Raymond James
Frontier Group upgraded to Outperform from Market Perform at Raymond James
06/10/22 JPMorgan
Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
05/05/22 Deutsche Bank
Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
UAL United Airlines
$36.98 /

+0.53 (+1.45%)

06/27/22 Evercore ISI
United Airlines price target lowered to $45 from $56 at Evercore ISI
06/23/22 Citi
Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
06/23/22 Raymond James
United Airlines price target lowered to $48 from $62 at Raymond James
ALK Alaska Air
$41.55 /

+0.4 (+0.97%)

06/27/22 Evercore ISI
Alaska Air price target lowered to $70 from $80 at Evercore ISI
06/23/22 Raymond James
Alaska Air downgraded to Outperform from Strong Buy at Raymond James
06/23/22 Raymond James
Alaska Air downgraded to Outperform from Strong Buy at Raymond James
04/22/22 JPMorgan
Alaska Air price target raised to $103 from $97 at JPMorgan
JBLU JetBlue
$8.57 /

+0.035 (+0.41%)

06/27/22 Evercore ISI
JetBlue price target lowered to $10 from $13 at Evercore ISI
04/26/22 JPMorgan
JetBlue double downgraded to Underweight from Overweight at JPMorgan
UAL United Airlines
$36.98 /

+0.53 (+1.45%)

SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

JBLU JetBlue
$8.57 /

+0.035 (+0.41%)

ALK Alaska Air
$41.55 /

+0.4 (+0.97%)

UAL United Airlines
$36.98 /

+0.53 (+1.45%)

SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

UAL United Airlines
$36.98 /

+0.53 (+1.45%)

SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

JBLU JetBlue
$8.57 /

+0.035 (+0.41%)

ALK Alaska Air
$41.55 /

+0.4 (+0.97%)

UAL United Airlines
$36.98 /

+0.53 (+1.45%)

SAVE Spirit Airlines
$24.14 /

-0.415 (-1.69%)

LUV Southwest
$36.52 /

-0.205 (-0.56%)

JBLU JetBlue
$8.57 /

+0.035 (+0.41%)

ALK Alaska Air
$41.55 /

+0.4 (+0.97%)

Hot Stocks
Verrica Pharmaceuticals director buys $10M in common stock » 16:49
07/05/22
07/05
16:49
07/05/22
16:49
VRCA

Verrica Pharmaceuticals

$2.51 /

+0.32 (+14.61%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$2.51 /

+0.32 (+14.61%)

VRCA Verrica Pharmaceuticals
$2.51 /

+0.32 (+14.61%)

05/31/22 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $12 from $20 at H.C. Wainwright
05/25/22 Needham
Verrica Pharmaceuticals downgraded to Hold at Needham after CRL
05/25/22 Needham
Verrica Pharmaceuticals downgraded to Hold from Buy at Needham
05/25/22 RBC Capital
Verrica downgraded to Sector Perform from Outperform at RBC Capital
VRCA Verrica Pharmaceuticals
$2.51 /

+0.32 (+14.61%)

  • 30
    Jun
VRCA Verrica Pharmaceuticals
$2.51 /

+0.32 (+14.61%)

Hot Stocks
Beyond Air director Carey acquires 175,000 common shares » 16:49
07/05/22
07/05
16:49
07/05/22
16:49
XAIR

Beyond Air

$8.45 /

+1.03 (+13.88%)

In a regulatory filing,…

In a regulatory filing, Beyond Air director Robert Carey disclosed the acquisition of 175,000 common shares of the company on June 30 at a price of $6.4474 per share.

ShowHide Related Items >><<
XAIR Beyond Air
$8.45 /

+1.03 (+13.88%)

XAIR Beyond Air
$8.45 /

+1.03 (+13.88%)

06/29/22 Truist
Beyond Air price target raised to $20 from $16 at Truist
06/29/22 Ladenburg
Beyond Air price target raised to $23 from $17 at Ladenburg
11/15/21 Roth Capital
Beyond Air price target raised to $15 from $11 at Roth Capital
11/12/21 Oppenheimer
Beyond Air price target raised to $13 from $9 at Oppenheimer
XAIR Beyond Air
$8.45 /

+1.03 (+13.88%)

XAIR Beyond Air
$8.45 /

+1.03 (+13.88%)

XAIR Beyond Air
$8.45 /

+1.03 (+13.88%)

Periodicals
Ben & Jerry's sues Unilever to block Israeli business sale, Reuters reports » 16:47
07/05/22
07/05
16:47
07/05/22
16:47
UL

Unilever

$45.84 /

-0.435 (-0.94%)

Ben & Jerry's is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UL Unilever
$45.84 /

-0.435 (-0.94%)

UL Unilever
$45.84 /

-0.435 (-0.94%)

05/16/22 Societe Generale
Unilever double downgraded to Sell at Societe Generale
05/16/22 Societe Generale
Unilever downgraded to Sell from Buy at Societe Generale
03/14/22 Bernstein
Unilever upgraded to Market Perform from Underperform at Bernstein
02/25/22 Goldman Sachs
Unilever reinstated with a Neutral at Goldman Sachs
UL Unilever
$45.84 /

-0.435 (-0.94%)

UL Unilever
$45.84 /

-0.435 (-0.94%)

UL Unilever
$45.84 /

-0.435 (-0.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.